Yi tsammanin samun COVID-19 Booster Shot Watanni 8 Bayan Tallafin ku na Asali

Wadatacce

• Bita don

Kwanaki kadan bayan Hukumar Abinci da Magunguna ta ba da izinin haɓaka rigakafin COVID-19 ga mutanen da ba su da rigakafi, an tabbatar da cewa za a sami harbi na COVID-19 na uku nan ba da jimawa ba ga mafi yawan Amurkawan da aka yiwa allurar rigakafi. Tun daga wata mai zuwa, waɗanda suka karɓi ko dai alluran rigakafin Pfizer-BioNTech biyu ko na Moderna za su cancanci samun haɓaka, in ji gwamnatin Biden a ranar Laraba.

A karkashin wannan shirin, za a gudanar da harbi na uku kusan watanni takwas bayan mutum ya karɓi kashi na biyu na allurar COVID-19. Za a iya fitar da masu haɓaka harbi na uku tun daga ranar 20 ga Satumba, Jaridar Wall Street Journal ya ruwaito Laraba. Amma kafin wannan shirin zai iya bisa hukuma fara aiki, dole ne FDA ta ba da izini ga masu haɓakawa da farko. Idan FDA ta ba da haske, ma'aikatan kiwon lafiya da tsofaffi za su kasance cikin waɗanda suka cancanci ƙarin ƙarin allurai, a cewar mashigar, da kuma duk wani wanda ya karɓi ɗayan jabs na farko.

Jami'an kiwon lafiya na Amurka a ranar Laraba a cikin wata sanarwa sun ce "Kariyar da ake samu yanzu daga munanan cututtuka, asibiti, da mutuwa na iya raguwa a cikin watanni masu zuwa, musamman a tsakanin wadanda ke cikin hadarin gaske ko kuma aka yi musu allurar rigakafin a farkon matakan rigakafin." "A saboda wannan dalili, mun yanke shawarar cewa za a buƙaci ɗaukar hoto mai ƙarfi don haɓaka kariyar da ke haifar da allurar rigakafi da tsawaita dorewar ta."

Lokacin da shi shine lokaci don samun ƙarin kuzari, za ku sami kashi na uku na allurar COVID-19 iri ɗaya da kuka karɓa tun farko, Jaridar Wall Street Journal ya ruwaito. Kuma yayin da wataƙila za a buƙaci ƙarfafawa ga masu karɓar allurar rigakafin Johnson & Johnson, har yanzu ana tattara bayanai kan lamarin, Jaridar New York Times ya ruwaito Litinin. (Mai alaƙa: Yaya Tallafin COVID-19 yake da inganci?)

Kwanan nan, Pfizer da BioNTech sun ƙaddamar da bayanai ga FDA don tallafawa allurai masu ƙaruwa na uku. Albert Bourla, Shugaba da Shugaba, Pfizer, a cikin sanarwar manema labarai ranar Litinin ya ce "Bayanan da muka gani har zuwa yau suna ba da shawarar kashi na uku na allurar rigakafinmu yana haifar da matakan rigakafi wanda ya zarce wanda aka gani bayan jadawalin farko na kashi biyu." "Mun yi farin cikin mika wadannan bayanan ga FDA yayin da muke ci gaba da aiki tare don magance kalubalen da ke tasowa na wannan annoba."

Daga cikin kalubalen kwanan nan na cutar ta COVID-19? Bambancin Delta mai saurin yaɗuwa, wanda a halin yanzu ya ƙidaya kashi 83.4 na lokuta a cikin Amurka, bisa ga bayanan kwanan nan daga Cibiyoyin Kula da Cututtuka da Cututtuka. Dangane da karuwar kararraki, an aiwatar da ƙarin umarni - kamar nuna shaidar allurar rigakafi - a sassa daban -daban na ƙasar, musamman New York City. (Mai dangantaka: Yadda ake Nuna Hujjar Allurar COVID-19 A NYC da Bayanta)

A halin yanzu, sama da Amurkawa miliyan 198 sun karɓi aƙalla kashi ɗaya na rigakafin COVID-19 yayin da miliyan 168.7 ke da cikakkiyar rigakafin, a cewar CDC. Tun daga ranar alhamis da ta gabata, FDA ta ɗauki wasu mutane-waɗanda ke da raunin tsarin garkuwar jiki da masu karɓar daskararwar gabobin jiki (kamar kodan, hanta, da zukata)-sun cancanci karɓar harbi na uku na ko Moderna ko Pfizer-BioNTech.

Kodayake sanya abin rufe fuska da nesantawar jama'a amintattu ne kuma ingantattun hanyoyi don taimakawa yaƙi da COVID-19, allurar da kanta ita ce mafi kyawun fare ba wai kawai kare kanku daga cutar ba har ma da wasu.

Bayanai a cikin wannan labarin daidai ne har zuwa lokacin da ake bugawa. Yayin da sabuntawa game da coronavirus COVID-19 ke ci gaba da haɓaka, yana yiwuwa wasu bayanai da shawarwari a cikin wannan labarin sun canza tun farkon bugawa. Muna ƙarfafa ku da ku bincika akai-akai tare da albarkatu kamar CDC, WHO, da sashin kula da lafiyar jama'a na gida don ƙarin sabbin bayanai da shawarwari.

Bita don